Based on our hypothesis that ESM-1 is an important prognostic factor for aggressive subtypes of breast cancers, we found that a high expression score of ESM-1 was associated with a higher grade and higher stages of breast cancer patients. The gene discussed is ESM1; the disease is breast carcinoma.